These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prostate specific antigen: clinical use in the diagnosis and management of prostate cancer. Kabalin JN. Geriatrics; 1992 Sep; 47(9):26-32. PubMed ID: 1380941 [Abstract] [Full Text] [Related]
9. Evaluation of prostate-specific antigen as a marker for adenocarcinoma of the prostate. Barak M, Mecz Y, Lurie A, Gruener N. J Lab Clin Med; 1989 May; 113(5):598-603. PubMed ID: 2469756 [Abstract] [Full Text] [Related]
11. [Prostate cancer screening using prostate-specific antigen (PSA) determinations in plasma. National Academy of Medicine]. Bourel M, Ardaillou R, Académie nationale de médecine. Bull Acad Natl Med; 2003 May; 187(5):985-95. PubMed ID: 14979060 [Abstract] [Full Text] [Related]
15. [Prostate-specific antigen as a prostatic tumor marker. Analysis of results in 206 patients]. Rodríguez Duarte C. Arch Esp Urol; 1991 May; 44(6):697-700. PubMed ID: 1722962 [Abstract] [Full Text] [Related]
16. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group]. Hirao Y, Ozono S, Kagebayashi Y, Yoshi M, Tani Y, Uemura H, Momose H, Okajima E. Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478 [Abstract] [Full Text] [Related]
18. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma. Recker F, Kwiatkowski MK, Piironen T, Pettersson K, Lümmen G, Wernli M, Wiefelspütz J, Graber SF, Goepel M, Huber A, Tscholl R. Cancer; 1998 Dec 15; 83(12):2540-7. PubMed ID: 9874461 [Abstract] [Full Text] [Related]